Yeast Gal4: a transcriptional paradigm revisited

被引：141
作者：
Traven, A
Jelicic, B
Sopta, M
机构：
[1] St Vincents Inst, Fitzroy, Vic 3065, Australia
[2] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia
来源：
EMBO REPORTS | 2006年 / 7卷 / 05期
关键词：
Gal4; RNA polymerase II; transcription; yeast;
D O I：
10.1038/sj.embor.7400679
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
During the past two decades, the yeast Gal4 protein has been used as a model for studying transcriptional activation in eukaryotes. Many of the properties of transcriptional regulation first demonstrated for Gal4 have since been shown to be reiterated in the function of several other eukaryotic transcriptional regulators. Technological advances based on the transcriptional properties of this factor-such as the two-hybrid technology and Gal4-inducible systems for controlled gene expression-have had far-reaching influences in fields beyond transcription. In this review, we provide an updated account of Gal4 function, including data from new technologies that have been recently applied to the study of the GAL network.
引用
收藏
页码：496 / 499
页数：4
相关论文
共 42 条
[1]   Transcriptional activating regions target a cyclin-dependent kinase [J].
Ansari, AZ ;
Koh, SS ;
Zaman, Z ;
Bongards, C ;
Lehming, N ;
Young, RA ;
Ptashne, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) :14706-14709
[2]   In vivo target of a transcriptional activator revealed by fluorescence resonance energy transfer [J].
Bhaumik, SR ;
Raha, T ;
Aiello, DP ;
Green, MR .
GENES & DEVELOPMENT, 2004, 18 (03) :333-343
[3]   Differential requirement of SAGA components for recruitment of TATA-box-binding protein to promoters in vivo [J].
Bhaumik, SR ;
Green, MR .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (21) :7365-7371
[4]   SAGA is an essential in vivo target of the yeast acidic activator Gal4p [J].
Bhaumik, SR ;
Green, MR .
GENES & DEVELOPMENT, 2001, 15 (15) :1935-1945
[5]   Recruitment of HAT complexes by direct activator interactions with the ATM-related tra1 subunit [J].
Brown, CE ;
Howe, L ;
Sousa, K ;
Alley, SC ;
Carrozza, MJ ;
Tan, S ;
Workman, JL .
SCIENCE, 2001, 292 (5525) :2333-2337
[6]   Can we eliminate placebo in ALS clinical trials? [J].
Bryan, WW ;
Hoagland, RJ ;
Murphy, J ;
Armon, C ;
Barohn, RJ ;
Goodpasture, JC ;
Miller, RG ;
Parry, GJ ;
Petajan, JH ;
Ross, MA ;
Stromatt, SC .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2003, 4 (01) :11-15
[7]   Gal80 confers specificity on HAT complex interactions with activators [J].
Carrozza, MJ ;
John, S ;
Sil, AK ;
Hopper, JE ;
Workman, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :24648-24652
[8]   The Gal4 activation domain binds Sug2 protein, a proteasome component, in vivo and in vitro [J].
Chang, C ;
Gonzalez, F ;
Rothermel, B ;
Sun, LP ;
Johnston, SA ;
Kodadek, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (33) :30956-30963
[9]   Cross-pathway regulation in Saccharomyces cerevisiae:: Activation of the proline utilization pathway by Gal4p in vivo [J].
D'Alessio, M ;
Brandriss, MC .
JOURNAL OF BACTERIOLOGY, 2000, 182 (13) :3748-3753
[10]   The Spt components of SAGA facilitate TBP binding to a promoter at a post-activator-binding step in vivo [J].
Dudley, AM ;
Rougeulle, C ;
Winston, F .
GENES & DEVELOPMENT, 1999, 13 (22) :2940-2945
12345